Table 5. Total distress scores for male and female patients in subgroups of therapy compared to no treatment.
Male
|
Female
|
Total
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Mean | s.d. | P1* | Mean | s.d. | P2* | Mean | s.d. | P3* | |
No treatment | 10.09 | 7.94 | 13.82 | 8.93 | 12.24 | 8.72 | <0.001 | ||
Surgery | 9.42 | 6.95 | NS | 13.33 | 8.50 | NS | 12.81 | 8.42 | <0.001 |
Chemotherapy | 18.44 | 8.72 | <0.001 | 20.86 | 9.26 | <0.001 | 19.86 | 9.11 | <0.001 |
Radiotherapy | 12.10 | 8.17 | NS | 16.45 | 9.46 | NS | 14.59 | 9.16 | NS |
Hormone therapy | 11.17 | 5.88 | NS | 17.99 | 9.72 | <0.001 | 17.66 | 9.66 | NS |
Other therapy | 19.38 | 9.88 | <0.001 | 22.04 | 9.78 | <0.001 | 20.99 | 9.89 | NS |
Surgery+chemotherapy | 18.46 | 9.66 | <0.001 | 19.10 | 9.37 | <0.001 | 18.97 | 9.41 | NS |
Surgery+radiotherapy | 13.37 | 5.48 | <0.001 | 14.21 | 7.28 | NS | 14.00 | 6.87 | NS |
Chemotherapy+radiotherapy | 15.12 | 7.62 | <0.001 | 16.51 | 8.12 | <0.001 | 15.99 | 7.96 | NS |
Surgery+chemotherapy+radiotherapy | 14.93 | 5.66 | <0.001 | 19.76 | 8.47 | <0.001 | 18.04 | 7.90 | NS |
*P1: difference between each therapy group and the non-treatment group within males; P2: difference between each therapy group and the non-treatment group within females; P3: differences between male and female patients within each therapy group; *P-values corrected for multiple testing.